Compare FGEN & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FGEN | GROW |
|---|---|---|
| Founded | 1993 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.6M | 32.2M |
| IPO Year | 2014 | N/A |
| Metric | FGEN | GROW |
|---|---|---|
| Price | $8.36 | $2.44 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $146.50 | N/A |
| AVG Volume (30 Days) | 40.1K | ★ 42.5K |
| Earning Date | 11-10-2025 | 11-12-2025 |
| Dividend Yield | N/A | ★ 3.70% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 53.38 | 0.07 |
| Revenue | $8,298,000.00 | ★ $8,546,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $0.16 | $37.27 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.85 | $2.02 |
| 52 Week High | $21.94 | $2.78 |
| Indicator | FGEN | GROW |
|---|---|---|
| Relative Strength Index (RSI) | 38.19 | 48.12 |
| Support Level | $7.99 | $2.42 |
| Resistance Level | $8.55 | $2.50 |
| Average True Range (ATR) | 0.33 | 0.09 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 49.45 | 60.32 |
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.